{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-040453","form_type":"8-K","ticker":"MGX","cik":"0001785279","company_name":"Metagenomi Therapeutics, Inc.","filed_at":"2025-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.850818+00:00","generated_at":"2026-05-24T16:02:16.718874+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Metagenomi enters $75M at-the-market equity distribution agreement with Jefferies","bullets":["Agreement with Jefferies to sell up to $75M of common stock via ATM offerings on Nasdaq.","Company is not obligated to sell any shares; sales are at Metagenomi's sole discretion.","Jefferies will receive a commission of up to 3.0% of gross proceeds from shares sold.","Shares to be offered under a new S-3 registration statement filed March 17, 2025.","No specific use of proceeds disclosed; proceeds may fund operations or R&D."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-040453","json":"https://secwatch.observer/filing/0000950170-25-040453.json","markdown":"https://secwatch.observer/filing/0000950170-25-040453.md","text":"https://secwatch.observer/filing/0000950170-25-040453.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025040453/0000950170-25-040453-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785279/000095017025040453/mgx-20250317.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T16:02:16.718874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}